• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Mercé Boada

Europe bursts onto the biotech scene as Grifols’ Phase 2b/3 plasma replacement therapy works in Alzheimer’s patients. Buy, sell or hold?

Steve Walker    November 15, 2018 November 15, 2018    No Comments on Europe bursts onto the biotech scene as Grifols’ Phase 2b/3 plasma replacement therapy works in Alzheimer’s patients. Buy, sell or hold?

The News: A blood plasma replacement therapy from Spanish company Grifols SA (Barcelona) reduced cognitive decline by 61% in patients with moderate Alzheimer’s disease compared with placebo, Labiotech.eu reports. The… Read more »

Disease, Investment, Pharmaceuticals    Alzheimer Management by Albumin Replacement, Alzheimer’s Disease, Antonio Páez, Blood Plasma, BrainVectis SAS, Clinical Trials on Alzheimer’s Disease, French Institute for Health and Medical Research, Fundació ACE, Grifols SA, Labiotech.eu, Mercé Boada, Nathalie Cartier-Lacave, Oryzon Genomics SA, ThePharmaLetter, Victor Grifols Roura

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Top Stories for Week of January 18, 2021
  • Top Stories for Week of January 11, 2021
  • Top Stories for Week of January 4, 2021
  • Top Stories for Week of December 21, 2020
    • China records more than 2,000 new coronavirus cases in 24 hours; CDC director says CIVUD-19 probably with us beyond this
    • Top Stories for Week of June 8, 2020
    • Top Stories for Week of August 10, 2020
    • Top Stories for Week of October 5, 2020
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress